Company intelligence / Profile preview
Synthon
Nijmegen, The Netherlandssynthon.com ↗
- Ownership
- Private
- Employees
- ~1600
- Development stage
- Commercial
01
Overview
Synthon is a commercial-stage pharmaceutical company that develops, manufactures, and out-licenses complex generic and hybrid medicines. The company has a marketed product portfolio of over 60 molecules covering multiple therapeutic areas.
- Therapeutic areas
- PsychiatryCardiovascularMen's HealthOncologyNeurology
- Modalities
- Small moleculescomplex genericshybrid medicines
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Works with 200+ marketing partners including the top 10 generic pharma companies
Beyond the preview
Go deeper on Synthon.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Synthon.